Epipen

What the EpiPen Recall Might Mean for You

EpiPen and EpiPen Jr auto-injectors distributed between December 2015 through July 2016 are being recalled. 

In early April,  pharmaceutical company Mylan NV announced a recall of certain brand name EpiPen products. The flaw in the recalled devices means that in a case of emergency, patients could face serious health risks. EpiPen

In a public statement, Mylan stated that “this recall is being conducted as a result of the receipt of two previously disclosed reports outside of the U.S. of failure to activate the device due to a potential defect in a supplier component.”

Mylan’s EpiPen, expanded its recall of the popular auto-Injectors to the U.S. In the recall announcement, Mylan made it clear that they would be readily available to replace the recalled devices. 

Epipen
Patients, customers and distributors are being notified and should refer to Mylan.com/EpiPenRecall for updates on product return and replacement instructions.

Further, the pharma giant stated that “there will be no additional replacement-related financial burden to them as a result of this recall.” 

Patients with the recalled auto-injectors could face serious consequences from anaphylaxis. Anaphylaxis is a life-threatening allergic reaction to things like insect bites, food, and medication. 

The recalled product was manufactured by Pfizer’s Meridian Medical Technologies and was distributed between December 2015 and July 2016 by Mylan Specialty.

If you or your loved one have been put at risk by the EpiPen or any other Mylan product, contact the legal professionals at Medical Claim Legal.